Dwight Porter
Presidente presso Biothera, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Steven J. Karel | M | - |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN.
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | 24 anni |
| Walter Ogier | M | 67 |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN.
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | 7 anni |
| Edward Woiteshek | M | - |
Valeas Capital Partners Management LP
 Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | 3 anni |
| Rob Little | M | - |
Valeas Capital Partners Management LP
Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | - |
| Bruno Osterwalder | M | - |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| Eric Cutsem | M | - |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| DIERKS MIKE | M | - |
Valeas Capital Partners Management LP
Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | 3 anni |
| Tanya Mayadas | F | - |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| Jonathan Reichner | M | - |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| Dario Herrera | M | - |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| Christian Holck | M | - |
Valeas Capital Partners Management LP
Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | 2 anni |
| Noah Viner | M | - |
Valeas Capital Partners Management LP
Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | 2 anni |
| Michael Grey | M | 71 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| Elina Onitskansky | F | - |
Valeas Capital Partners Management LP
Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | - |
| Alexander R. Giaquinto | M | 80 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| Brent Ahrens | M | 61 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | - |
| Smith Stephen | M | - |
Valeas Capital Partners Management LP
Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jeremy Graff | M | - |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 6 anni |
| Barry A. Labinger | M | 60 |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 3 anni |
| Del Marting | M | 77 |
United States Navy (District of Columbia)
| 3 anni |
| David Ross | M | - |
United States Navy (District of Columbia)
| 3 anni |
| David M. Wood | M | - |
United States Navy (District of Columbia)
| 5 anni |
| Andrew LaFrence | M | 61 |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 1 anni |
| Edward Moser | M | - |
United States Navy (District of Columbia)
| 5 anni |
| Luke Sampson | M | - |
United States Navy (District of Columbia)
| 4 anni |
| Bradford G. Phillips | M | - |
United States Navy (District of Columbia)
| 23 anni |
| Annalisa Jenkins | M | 58 |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 3 anni |
| Clyde B. Blandford | M | - |
United States Navy (District of Columbia)
| - |
| John William Warner | M | - |
United States Navy (District of Columbia)
| - |
| Richard Banchoff | M | - |
United States Navy (District of Columbia)
| 3 anni |
| Hal Eberling | M | - |
United States Navy (District of Columbia)
| 2 anni |
| Ray N. Wareham | M | - |
United States Navy (District of Columbia)
| 2 anni |
| Richard Huhn | M | - |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 5 anni |
| Robert J. Martin | M | - |
United States Navy (District of Columbia)
| 5 anni |
| Robert Felton | M | 85 |
United States Navy (District of Columbia)
| 8 anni |
| Stephen Daniel Johnson | M | - |
United States Navy (District of Columbia)
| 6 anni |
| Thomas E. Weil | M | - |
United States Navy (District of Columbia)
| 5 anni |
| John E. Minton | M | 76 |
United States Navy (District of Columbia)
| 3 anni |
| Mann Shoffner | M | - |
United States Navy (District of Columbia)
| 7 anni |
| Peter F. Collura | M | 74 |
United States Navy (District of Columbia)
| 4 anni |
| Karl F. Loomis | M | 76 |
United States Navy (District of Columbia)
| 26 anni |
| Patricia Tracey | F | 73 |
United States Navy (District of Columbia)
| 35 anni |
| William Si Garrett | M | - |
United States Navy (District of Columbia)
| 11 anni |
| Donald Roger Brooke Liddell | M | - |
United States Navy (District of Columbia)
| 5 anni |
| Fred W. Klein | M | - |
United States Navy (District of Columbia)
| 3 anni |
| Richard M. Denham | M | - |
United States Navy (District of Columbia)
| - |
| Clifford C. Cook | M | - |
United States Navy (District of Columbia)
| 4 anni |
| Ernest Pomerantz | M | - |
United States Navy (District of Columbia)
| 5 anni |
| Walter Galvin | M | 77 |
United States Navy (District of Columbia)
| 3 anni |
| James Tobin | M | 79 |
United States Navy (District of Columbia)
| 4 anni |
| Michele Gargano | F | - |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 51 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Dwight Porter
- Contatti personali
